Skip to main content
Figure 2 | Lipids in Health and Disease

Figure 2

From: Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia

Figure 2

Ezetimibe improved apolipoprotein B (apoB) to apolipoprotein A-I (apoA-I) ratio in patients with hypercholesterolemia. Ezetimibe improved apoB to apoA-I ratio in patients with hypercholesterolemia. apoB and apoA were measured before and after 22-week ezetimibe administration in patients with atherosclerosis-prone hypercholesterolemia (n = 14). Bars represent the mean value of the ratio ± SD.

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X